Who founded Novadip Biosciences?

Novadip Biosciences was founded by Dr. Denis Dufrane.

Who are Novadip Biosciences's investors?

Novadip Biosciences's investors include New Science Ventures, Épimède, Fund+, VIVES Partners, Sambrinvest, Wallonie Entreprendre.

Where is Novadip Biosciences headquartered?

Novadip Biosciences is headquartered in Louvain, BE.

Novadip Biosciences

Louvain, BE · 11 known investors

Find your way into Novadip Biosciences

Paths you didn't know you had: your email and LinkedIn already hold routes to the Novadip Biosciences team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Novadip develops regenerative medicine treatments using its 3M3 tissue regeneration platform to address conditions requiring bone and tissue repair, including spinal fusion, cancer recovery, and complex fractures.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Dr. Denis DufraneFounder & ProfessorDr. Denis Dufrane holds a PhD in cell transplantation from Université catholique de Louvain and brings expertise in stem cells, molecular biology, and tissue engineering from his work as Chief Scientific Officer in the biotechnology sector. He is founder of Novadip, which develops regenerative medicine treatments for bone and tissue repair conditions.

Board

Eric Paul PâquesChairman

Investors · 11

New Science Ventures✓ confirmed by Novadip BiosciencesGreenwich · $2M – $8M

How we know: New Science Ventures's portfolio page · the company's own site · newscienceventures.com · funding news feeds · the VCSheet dataset · Not right? Tell us

Épimèdelisted by ÉpimèdeLiège · $1M – $7M

How we know: Épimède's portfolio page · Not right? Tell us

Fund+listed by Fund+Leuven · $5.5M – $16.5M

How we know: Fund+'s portfolio page · newscienceventures.com · Not right? Tell us

VIVES Partnerslisted by VIVES PartnersWavre · $108K – $7.6M

How we know: VIVES Partners's portfolio page · Not right? Tell us

SambrinvestreportedCharleroi

How we know: funding news feeds · Not right? Tell us

Wallonie EntreprendrereportedLiège

How we know: funding news feeds · Not right? Tell us

Also in the syndicate · 5

CR-CP Life Science FundleadInvest BWInvestSudSRIW Life SciencesleadVIVES Louvain Technology Fund

Funding

SEC filings, press & company announcements

Undisclosed amountSeries BOct 2021
CR-CP Life Science Fund (lead), Fund+ (lead), New Science Ventures (lead), SRIW Life Sciences (lead), Invest BW, InvestSud, VIVES Louvain Technology Fund
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Novadip Biosciences Raises Additional EUR 40 Million Bringing Total Company Funding to EUR 88 Million | Novadipnovadip.com · Nov 2022

Novadip Investment Opportunities | 88 Million in Fundingnovadip.com · Sep 2022

Frequently asked questions

What does Novadip Biosciences do?: Novadip develops regenerative medicine treatments using its 3M3 tissue regeneration platform to address conditions requiring bone and tissue repair, including spinal fusion, cancer recovery, and complex fractures.
Who founded Novadip Biosciences?: Novadip Biosciences was founded by Dr. Denis Dufrane.
Who are Novadip Biosciences's investors?: Novadip Biosciences's investors include New Science Ventures, Épimède, Fund+, VIVES Partners, Sambrinvest, Wallonie Entreprendre.
Where is Novadip Biosciences headquartered?: Novadip Biosciences is headquartered in Louvain, BE.